Imaging of Trabeculectomy Blebs Using the Spectral Domain Optical Coherence Tomography

Imaging of Blebs After Trabeculectomy With Mitomycin C 0,02% Using the Spectral Domain Optical Coherence Tomography

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01391676

Acronym

SDOCT-TE

Enrollment

Registered

2011-07-12

Start date

2011-03-31

Completion date

2011-12-31

Last updated

2013-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Filtering Blebs, Glaucoma

Keywords

glaucoma, trabeculectomy, filtering bleb, spectral domain optical coherence tomography

Brief summary

The aim of this study is imaging of trabeculectomy blebs regarding structure and function with the spectral domain optical coherence tomography.

Detailed description

After a trabeculectomy with mitomycin C 0,02% for 3 minutes, the blebs are controlled by a glaucoma specialist on day 1, week 1,2,3,4, month 3 and 6 after surgery. The glaucoma specialist will evaluate the bleb appearance according to a standardized protocol. At the same time points the bleb will be imaged with the spectral domain optical coherence tomography, to monitor bleb changes objectively. The investigators hope to see signs of bleb incapsulation and scarring earlier and then treat the patient accordingly.

Interventions

PROCEDUREtrabeculectomy

postoperative imaging of trabeculectomy blebs with the spectral domain optical coherence tomography

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

glaucoma patients who need a trabeculectomy with mitomycin C 0,02% for further reduction of intraocular pressure, informed consent

Exclusion criteria

patient without glaucoma, under 18 years of age, not willing to take part in the study

Design outcomes

Primary

Measure	Time frame
grading of filtering bleb	December 2011

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026